GE HealthCare Technologies (GEHC) Cost of Revenue (2022 - 2026)

GE HealthCare Technologies (GEHC) has 5 years of Cost of Revenue data on file, last reported at $481.0 million in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue fell 19.57% year-over-year to $481.0 million; the trailing twelve-month figure through Mar 2026 stood at $2.8 billion (up 251.93% YoY), and the FY2025 full-year result was $3.4 billion, up 78.03% from the prior year.
• Cost of Revenue for Q1 2026 stood at $481.0 million, down from $887.0 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $2.1 billion in Q3 2023 and bottomed at -$5.0 billion in Q4 2023.
• The 5-year median for Cost of Revenue is $751.0 million (2022), against an average of $12.5 million.
• The widest annual swing landed in 2024, when Cost of Revenue sank 60.4%; it then jumped 121.56% in 2025.
• A 5-year view of Cost of Revenue shows it stood at -$3.4 billion in 2022, then slumped by 49.27% to -$5.0 billion in 2023, then increased by 17.78% to -$4.1 billion in 2024, then surged by 121.56% to $887.0 million in 2025, then slumped by 45.77% to $481.0 million in 2026.
• The last three Cost of Revenue figures came in at $481.0 million (Q1 2026), $887.0 million (Q4 2025), and $884.0 million (Q3 2025), per Business Quant data.

Peer Comparison